Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06511661 | Prognostic Significance of the Uncertain Resection in NSCLC | unknown | — | 3,783 | Sun Yat-sen UniversityOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT05013099 | Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies(iPREDICT) | unknown | Phase 2 | 70 | ImaginAb, Inc.INDUSTRY | 6 | Jul 22, 2024 | clinicaltrials |
| NCT05987345 | Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer | unknown | N/A | 10 | Energenx Medical LTD.INDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06331455 | Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection(SUPER) | unknown | Phase 2 | 12 | Marc de PerrotOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06512142 | Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution(SmartLungs) | unknown | — | 30,000 | University of Medicine and Pharmacy "Victor Babes" TimisoaraOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT05837429 | Low Volume High Intensity Interval Training in Operated Lung Cancer Patients | unknown | N/A | 40 | Hacettepe UniversityOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT04712877 | Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers | unknown | — | 1,000 | Lung Cancer Mutation ConsortiumNETWORK | 1 | Jul 17, 2024 | clinicaltrials |
| NCT05183243 | GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results | unknown | Phase 1 | 68 | Suzhou Genhouse Bio Co., Ltd.OTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT05271292 | Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.(SCLC) | unknown | Phase 1 / Phase 2 | 36 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06503042 | A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC | unknown | — | 100 | Tang-Du HospitalOTHER | 0 | Jul 16, 2024 | clinicaltrials |
| NCT01456429 | Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.(ASTER2) | unknown | N/A | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 2 | Jul 15, 2024 | clinicaltrials |
| NCT06497686 | The Application of Rapid Fresh Digital Pathology on the Diagnosis and Biomarker Testing of Lung Cancer | unknown | — | 300 | National Taiwan University HospitalOTHER | 0 | Jul 15, 2024 | clinicaltrials |
| NCT06499454 | Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument | unknown | — | 50 | Ruby Robotics IncINDUSTRY | 0 | Jul 12, 2024 | clinicaltrials |
| NCT06362980 | A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations(EGFR) | unknown | Phase 1 | 20 | National Cancer Center, ChinaOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06494800 | Added Value of PET/CT in Lung Cancer | unknown | — | 30 | Sohag UniversityOTHER | 0 | Jul 10, 2024 | clinicaltrials |
| NCT05244213 | Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC(NEOTIDE) | unknown | Phase 2 | 35 | Guangdong Provincial People's HospitalOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT05543954 | 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients | unknown | Early Phase 1 | 60 | Peking Union Medical College HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT04562337 | SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC | unknown | Phase 2 | 67 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06483919 | The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer | unknown | — | 228 | Jinming YuOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT06485557 | A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC | unknown | Phase 3 | 90 | Tang-Du HospitalOTHER | 0 | Jul 3, 2024 | clinicaltrials |
| NCT04807114 | A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC | unknown | — | 70 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06479005 | ETERNALS: Remote Monitoring in Lung Cancer Patients(ETERNALS) | unknown | N/A | 50 | Ziekenhuis Oost-LimburgOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06118229 | A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients | unknown | — | 300 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06479759 | LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer(ACCLAIM) | unknown | Phase 2 | 50 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT04432857 | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors | unknown | Phase 1 | 63 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 2 | Jun 27, 2024 | clinicaltrials |
| NCT05060432 | Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors(TIG-006) | unknown | Phase 1 / Phase 2 | 153 | iTeos Belgium SAINDUSTRY | 6 | Jun 21, 2024 | clinicaltrials |
| NCT06409416 | Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer | unknown | — | 20 | Casa Sollievo della Sofferenza IRCCSOTHER | 0 | Jun 18, 2024 | clinicaltrials |
| NCT05816499 | Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)(AK104IIT018) | unknown | Phase 1 / Phase 2 | 50 | Shanghai Chest HospitalOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT06463171 | Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer | unknown | Phase 2 | 60 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT04818333 | A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 157 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 13, 2024 | clinicaltrials |
| NCT06456203 | Trial of Artificial Intelligence for Chest Radiography(ACER) | unknown | N/A | 10,000 | Duke-NUS Graduate Medical SchoolOTHER | 0 | Jun 13, 2024 | clinicaltrials |
| NCT05110131 | Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy | unknown | N/A | 142 | Seoul National University Bundang HospitalOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06448455 | Observation on the Frailty Status of Lung Cancer Patients | unknown | — | 200 | Peking University Third HospitalOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT04506359 | Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients | unknown | N/A | 300 | National Taiwan University HospitalOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06313541 | Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy | unknown | Phase 2 | 146 | Fudan UniversityOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT04322578 | Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC(CONFIRM) | unknown | Phase 2 | 120 | Hunan Province Tumor HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05818449 | Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)(DigiNet) | unknown | N/A | 850 | University of CologneOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06441357 | Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter | unknown | — | 2,000 | Tang-Du HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06254196 | Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies(Telenursing) | unknown | N/A | 40 | Regina Elena Cancer InstituteOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06436885 | An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer | unknown | Early Phase 1 | 39 | Henan Cancer HospitalOTHER_GOV | 1 | May 31, 2024 | clinicaltrials |
| NCT06436040 | Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma | unknown | — | 40 | Tang-Du HospitalOTHER | 1 | May 30, 2024 | clinicaltrials |
| NCT03705546 | The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer | unknown | — | 1,050 | Samsung Medical CenterOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04945928 | Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC | unknown | N/A | 30 | Ruijin HospitalOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT05878028 | L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC | unknown | Phase 2 | 33 | Quanli GaoOTHER_GOV | 1 | May 23, 2024 | clinicaltrials |
| NCT03724500 | Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer | unknown | — | 65 | Chang Gung Memorial HospitalOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06424821 | Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC(LungCadX) | unknown | Phase 2 | 54 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT05964101 | Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma(GALAXY-1) | unknown | Phase 2 | 25 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06422546 | A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC(pre-FLAME) | unknown | — | 950 | Beijing Cancer Prevention & Treatment SocietyOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06423066 | Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jul 25, 2024source: clinicaltrials